S100A4 and Cestode infectious disease: Niclosamide, an approved antihelminthic drug for the treatment of tapeworm infections, inhibited metastasis formation in a mouse model of colon cancer by blocking S100A4 expression and its effects on the WNT/CTNNB1 signaling pathway [24].